Search Results 111-120 of 17355 for Proto-oncogene

  1. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  2. MC1R-targeted Alpha-particle Monotherapy And Combination Therapy Trial With Nivolumab In Adults With Advanced Melanoma - Mayo Clinic

    * Subjects on prior intravenous therapy (e.g., chemotherapy or checkpoint inhibitors), or prior oral therapy (e.g.,proto-oncogene B-RAF or mitogen-activated ...

  3. Clinical trials - Oncology (Medical)

    Molecular characterization may include short tandem DNA repeat; STR) and oncogenic/tumor suppressor gene mutation analyses to assure that the derived models ...

  4. Publications - Debra A. Bell, M.D. - Mayo Clinic

    Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res. 1993 Apr 1; 53(7):1489-92. View PubMed; Goff BA, Muntz ...

  5. A Study To Analyze Isolation, Activation And Expansion Of Mutation Reactive T-cells - Mayo Clinic

    Circulating cell-free DNA (cfDNA) from the plasma will be extracted and sequenced to identify somatic mutations that were exposed to the T-cells. Participation ...

  6. Focus areas - Department of Molecular Medicine - Mayo Clinic Research

    The Department of Molecular Medicine at Mayo Clinic is focused on targeting cancer using gene therapy and viruses to kill cancer cells.

  7. Establishment Of Preclinical Models From Patients With Gynecological Malignancies - Mayo Clinic

    In this study, we make and test preclinical models of gynecological cancers (ovarian, fallopian tube, peritoneal, uterine, vulvar, cervix, and vaginal) of any ...

  8. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...

  9. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    Oncogene. 2013; doi:10.1038/onc.2012.628. Ingle JN, et al. Estrogens and their precursors in postmenopausal women with early breast cancer receiving ...

  10. Inotuzumab Ozogamicin And Post-Induction Chemotherapy In Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, And B-LLy - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...